Terms: = Prostate cancer AND NUMA1, Q14980, 4926, ENSG00000137497, NUMA
6 results:
1. Patient-reported functional outcome measures and treatment choice for prostate cancer.
Tiruye T; O'Callaghan M; Moretti K; Jay A; Higgs B; Santoro K; Boyle T; Ettridge K; Beckmann K
BMC Urol; 2022 Nov; 22(1):169. PubMed ID: 36335325
[TBL] [Abstract] [Full Text] [Related]
2. Lower Urinary Tract Infection and Subsequent Risk of prostate cancer: A Nationwide Population-Based Cohort Study.
Fan CY; Huang WY; Lin KT; Lin CS; Chao HL; Yang JF; Lin CL; Kao CH
PLoS One; 2017; 12(1):e0168254. PubMed ID: 28046120
[TBL] [Abstract] [Full Text] [Related]
3. Phosphorylation of numa by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase numa localization.
Toughiri R; Li X; Du Q; Bieberich CJ
J Cell Biochem; 2013 Apr; 114(4):823-30. PubMed ID: 23097092
[TBL] [Abstract] [Full Text] [Related]
4. Immunolocalization of numa and phosphorylated proteins during the cell cycle in human breast and prostate cancer cells as analyzed by immunofluorescence and postembedding immunoelectron microscopy.
Gobert GN; Hueser CN; Curran EM; Sun QY; Glinsky VV; Welshons WV; Eisenstark A; Schatten H
Histochem Cell Biol; 2001 May; 115(5):381-95. PubMed ID: 11449886
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear mitotic apparatus protein (numa) in benign and malignant diseases.
Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt UM; Schmeller N; Schalhorn A
Anticancer Res; 1999; 19(4A):2415-20. PubMed ID: 10470168
[TBL] [Abstract] [Full Text] [Related]
6. Utilization of nuclear matrix proteins for cancer diagnosis.
Keesee SK; Briggman JV; Thill G; Wu YJ
Crit Rev Eukaryot Gene Expr; 1996; 6(2-3):189-214. PubMed ID: 8855388
[TBL] [Abstract] [Full Text] [Related]
